Start for free
Start for free
ShangPharma logo

ShangPharma

Asia, Shanghai, China, Shanghai

Description

ShangPharma is a leading China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides

Investor Profile

ShangPharma has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (60%)
  • Series B (40%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Clinical Trials
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ShangPharma frequently co-invest with?

Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Omega Funds
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 2
Pfizer Venture Investments
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Schrödinger
Schrödinger
North America, New York, United States, New York
Co-Investments: 2
Lifeforce Capital
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 2
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
SR One
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
AbbVie Biotech Ventures
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 1

Which angels does ShangPharma often collaborate with?

TA
Timothy A. Springer
North America, Massachusetts, United States, Cambridge
Shared Deals: 2

What are some of recent deals done by ShangPharma?

Circle Pharma

San Francisco, California, United States

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series BMar 17, 2020
Amount Raised: $45,000,000
Morphic Therapeutic

Waltham, Massachusetts, United States

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series BSep 25, 2018
Amount Raised: $80,000,000
Obsidian Therapeutics

Cambridge, Massachusetts, United States

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

BiotechnologyHealth CarePharmaceutical
Series ADec 6, 2017
Amount Raised: $49,500,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series ADec 21, 2016
Amount Raised: $4,500,000
Morphic Therapeutic

Waltham, Massachusetts, United States

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series AJun 30, 2016
Amount Raised: $51,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator